Literature DB >> 30096250

Association of Desmin Gene Variant rs1058261 with Cardiovascular Disease, the TAMRISK Study.

Jaakko Piesanen1, Tarja Kunnas1, Seppo T Nikkari1.   

Abstract

AIMS: Since desmin expression is diminished in vascular smooth muscle cells during reparative processes, we wanted to study whether a common intragenic single nucleotide polymorphism at nucleotide position 828 (rs1058261) of the DES gene associates with hypertension, cerebrovascular complications, and all cardiovascular events in the Tampere adult population cardiovascular risk (TAMRISK) study.
MATERIALS AND METHODS: A Finnish periodic health examination cohort of 336 subjects with diagnosed hypertension and 473 controls were analyzed. Samples were genotyped for polymorphism using TaqMan techniques. Prevalence of ischemic heart diseases, incidence of cerebrovascular diseases, and transient cerebral ischemic attacks (TIAs) were obtained by self-report and the National Hospital Discharge Registry (HILMO).
RESULTS: There was no association of any of the rs1058261 genotypes with hypertension at the age of 50. When the subjects were followed to the age of 60, after adjustment for gender and body mass index, subjects with the genotype CC had higher incidence of cerebrovascular events (cerebrovascular diseases and TIA) (4.1%) compared with the T allele (1.6%) (p = 0.046). In addition, those with CC genotype had a higher incidence of all combined cardiovascular events (12.8%) compared with subjects with the T allele (8.5%) (p = 0.028).
CONCLUSIONS: Our findings suggest that variations in the DES gene may be involved in cardiovascular disease.

Entities:  

Keywords:  desmin; genetic variation; intermediate filaments/genetics; vascular diseases

Mesh:

Substances:

Year:  2018        PMID: 30096250     DOI: 10.1089/gtmb.2018.0118

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  1 in total

1.  The gene variant for desmin rs1058261 may protect against combined cancer and cardiovascular death, the Tampere adult population cardiovascular risk study.

Authors:  Jaakko Piesanen; Tarja Kunnas; Seppo T Nikkari
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.